9/7/2016 4:58 pm
Date / Time filed with the Register of Regulations 		VA.R. Document Number: R____-______
Virginia Register Publication Information

Transmittal Sheet: Response to Petition for Rulemaking
Initial Agency Notice
X
Agency Decision
Promulgating Board: Board of Pharmacy
Regulatory Coordinator: Elaine J. Yeatts

(804)367-4688

elaine.yeatts@dhp.virginia.gov
Agency Contact: Caroline Juran, RPh

Executive Director

(804)367-4416

caroline.juran@dhp.virginia.gov
Contact Address: Department of Health Professions

9960 Mayland Drive

Suite 300

Richmond, VA 23233
Chapter Affected:
18 vac 110 - 20: Regulations Governing the Practice of Pharmacy
Statutory Authority: State: Chapters 33 and 34 of Title 54.1

Federal:
Date Petition Received 05/06/2016
Petitioner Derek Phillips
 Petitioner's Request
If deemed appropriate by the pharmacist, a patient may receive, upon request, drug quantities in excess of the face amount of a prescription for a Schedule VI substance, up to the total amount authorized.
 Agency Plan
In accordance with Virginia law, the petition has been filed with the Register of Regulations and will be published on May 30, 2016.  Comment on the petition may be sent by email, regular mail or posted on the Virginia Regulatory Townhall at www.townhall.virginia.gov; comment will be requested until June 29, 2016. Following receipt of all comments on the petition to amend regulations, the Board will decide whether to make any changes to the regulatory language in Regulations Governing the Practice of Pharmacy.  This matter will be on the Board's agenda for its meeting scheduled for September 7, 2016, and the petitioner will be informed of the Board's decision on his request after that meeting.
Publication Date 05/30/2016  (comment period will also begin on this date)
Comment End Date 06/29/2016
 Agency Decision
Initiate a regulatory change
Agency Response Date 09/07/2016
 Agency Decision Text
At its meeting on September 7, 2016, the Board considered the petition and a public comment in support.  The Board concluded it will issue a Notice of Intended Regulatory Action to consider an amendment to requirements for dispensing to allow dispensing of Schedule VI drugs in excess of the quantity on the prescription within the amount authorized.